Enarodustat clinical trials
Also written JTZ-951.
How each study uses enarodustat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the enarodustat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
9 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 3
Akros Pharma Inc. (4) · Peking Union Medical College Hospital (2) · JW Pharmaceutical (1) · Shenzhen Salubris Pharmaceuticals Co., Ltd. (1) · Shanghai Zhongshan Hospital (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test enarodustat.
- Jun 2027Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD PatientsPhase 4 · Shenzhen Salubris Pharmaceuticals Co., Ltd.
Studies
Open first, then newest update. How each study uses enarodustat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAANot yet recruitingPhase 3Peking Union Medical College HospitalNCT07548671Written as Enarodustat
- Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney DiseaseRecruitingPhase 4Shanghai Zhongshan HospitalNCT06725810Written as Enarodustat
- Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD PatientsNot yet recruitingPhase 4Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07079579Written as Enarodustat 2mg
- Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAAWithdrawnPhase 3Peking Union Medical College HospitalNCT07522996Written as Enarodustat
- A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.CompletedPhase 3JW PharmaceuticalNCT04027517Written as JTZ-951
- Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on HemodialysisCompletedPhase 1Akros Pharma Inc.NCT02805244Written as JTZ-951, 14C-JTZ-951
- Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal DiseaseCompletedPhase 1Akros Pharma Inc.NCT02581124Written as JTZ-951
- Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal DiseaseCompletedPhase 1Akros Pharma Inc.NCT01971164Written as JTZ-951
- Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal DiseaseCompletedPhase 1Akros Pharma Inc.NCT01978587Written as JTZ-951
Codes
What other systems call enarodustat · ClinicalTrials.gg INT001255
- MeSH (NLM) C000656654enarodustatConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) JSK7TUA223ENARODUSTATConfirmed FDA, NLM, Wikidata
- Wikidata Q107256608enarodustatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169944EnarodustatOne source FDA
- DrugBank DB14985One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000656654 | enarodustat | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | JSK7TUA223 | ENARODUSTAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q107256608 | enarodustat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169944 | Enarodustat | One source FDA |
| DrugBank | DB14985 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.